Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Brief communication: rituximab in HIV-associated multicentric Castleman disease. HIV-associated multicentric Castleman disease is a rare lymphoproliferative disorder with marked systemic symptoms attributed to cytokine disarray. Many therapeutic approaches in small series of patients have proved largely unsuccessful to date. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of internal medicine Pubmed

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Brief communication: rituximab in HIV-associated multicentric Castleman disease.


Abstract

HIV-associated multicentric Castleman disease is a rare lymphoproliferative disorder with marked systemic symptoms attributed to cytokine disarray. Many therapeutic approaches in small series of patients have proved largely unsuccessful to date.

Loading next page...
 
/lp/pubmed/brief-communication-rituximab-in-hiv-associated-multicentric-castleman-PEGrBWo4NL

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0003-4819
DOI
10.7326/0003-4819-147-12-200712180-00003
pmid
18087054

Abstract

HIV-associated multicentric Castleman disease is a rare lymphoproliferative disorder with marked systemic symptoms attributed to cytokine disarray. Many therapeutic approaches in small series of patients have proved largely unsuccessful to date.

Journal

Annals of internal medicinePubmed

Published: Jan 14, 2008

There are no references for this article.